Randomized, Double-Blind Clinical Evaluation of the Efficacy and Safety of Topical Eflornithine HCl 13.9% Cream in the Treatment of Women with Facial Hair

    John E. Wolf, Douglas Shander, Ferdinand Huber, Joseph Jackson, Chensheng Lin, Barbara Mathes, Kathy Schrode
    The study conducted a randomized, double-blind clinical trial to evaluate the efficacy and safety of topical eflornithine HCl 13.9% cream for treating facial hair in women. The results demonstrated that the cream was effective in reducing facial hair growth. The study involved a significant number of participants, which strengthened the reliability of the findings. The treatment was generally well-tolerated, with minimal adverse effects reported, indicating that eflornithine HCl 13.9% cream was a safe and effective option for managing unwanted facial hair in women.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results